Correlation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patients

Table 1 Demographic of mycophenolate mofetil treated patients and procedures (170 patients, 184 procedures) (%)

Characteristic
mean age	57.05
Female	89 (48.4)
Indication for procedure2
Screening	72 (39.1)
Diarrhea	51 (27.7)
Bleeding	24 (13.0)
Anemia	20 (10.9)
Abdominal pain	14 (7.7)
Constipation	3 (1.6)
Weight loss	3 (1.6)
Abnormal imaging	3 (1.6)
Bloating	1 (0.52)
Other (history of IBD, amyloid, stricture)	9 (4.9)
Indication for MMF
Organ transplant (kidney, liver, lung)	116
Autoimmune	35
Blood disorder	7
Unknown indication	26
Abnormal mucosa (gross)	40
With normal biopsies	10
With abnormal biopsies	25 (2 duplicates)
Without biopsies1	5
Normal mucosa (gross)	144
With normal biopsies	44 (normal biopsy or polypectomy, 1 for mass)
With abnormal biopsies	17 (1 duplicate)
Without biopsies1	83

¹Without biopsies done or with reports unavailable;

²Some procedures with multiple indications documented. MMF: Mycophenolate mofetil; IBD: Inflammatory bowel disease.